CVS and Aetna complete their merger
Published by Consumer Affairs
CVS Health and Aetna have completed their merger, combining a national retail pharmacy chain with a major health insurance provider.
The two companies positioned their merger as a way to make it easier and cheaper to access healthcare. CVS Health CEO Larry J. Merlo said the combination of the companies’ capabilities will transform the consumer health experience.
“As the front door to quality health care, our combined company will have a community focus, engaging consumers with the care they need when and where they need it, will simplify a complicated system and will help people achieve better health at a lower cost,” Merlo said. “We are also leading change in health care by challenging the status quo with new technologies, business models and partnerships.”
He also says that will lead consumers on their path to better health. Maybe so, but there are plenty of health advocates who worry that too many health decisions are being centered in one company. The Senior Care Pharmacy Coalition (SCPC) notes the merger could cause access problems for seniors and make drugs more expensive.
Worries about consolidation
“The completion of the CVS-Aetna merger should incentivize Congress to scrutinize how rapid, massive consolidation in the healthcare industry — especially in conjunction with the proposed CMS (Centers for Medicare and Medicaid Services) rule — will crush choice and competition at the expense of seniors in skilled nursing and assisted living facilities (SNFs/ALFs),” said Alan Rosenbloom, CEO of SCPC.
Rosenbloom says his organization has been alarmed that large healthcare companies are dominating a number of related markets, including pharmacy benefits managers (PBM), retail, mail-order, specialty, and LTC pharmacy.
“Now two of these companies, including CVS Health, have added health insurance and Medicare Part D insurance as components of their cross-market oligopolies,” Rosenbloom said. “This merger and acquisition activity, rapid vertical and horizontal integration and stubborn adherence to non-transparent business practices threatens the nation’s commitment to free and fair markets — and ultimately places LTC pharmacies at a competitive disadvantage.”
LTC pharmacies are those that serve a specialized population of seniors who live in skilled nursing and assisted living centers. Rosenbloom says the typical patient takes 12 or more medications a day.
But Merlo insists the combination of CVS and Aetna will prove to be a plus for all consumers. He says fully integrating Aetna’s medical information and analytics with CVS Health’s pharmacy data will benefit patients by leading to earlier interventions and better-connected care. That, he says, will lead to better outcomes and lower costs.
Click here to see the original article on the Consumer Affairs website.
Senior Care Pharmacy Coalition and ATI Advisory Share New Analysis of Medicare Beneficiaries Demonstrating Common Long-Term Care Needs Across Settings
The Senior Care Pharmacy Coalition (SCPC) and ATI Advisory (ATI) have released a new analysis finding that 75% of Medicare beneficiaries who need long-term care (LTC) live in the community, while only 25% live in nursing homes or assisted living communities. Nearly 60% of the community-dwelling population with LTC needs also have four or more chronic conditions and fill 10 or more prescription medications a year.
Check out SCPC CEO Alan Rosenbloom on the Pharmacy Podcast Network’s “PBM Reform Podcast”
SCPC President and CEO Alan Rosenbloom speaks with the Pharmacy Podcast Network the importance of advocating for PBM reform, the status of the LTC Pharmacy Definition Act, LTC Pharmacy at-home, drug pricing legislation and its implications for LTC Pharmacy, and more.
SCPC Applauds House Oversight and Accountability Committee Chair James Comer for Launching Investigation into PBM Practices
The Senior Care Pharmacy Coalition (SCPC), the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies, applauds House Committee on Oversight and Accountability Chairman James Comer (R-KY) for launching an investigation into pharmacy benefit managers (PBMs) and their tactics that are harming patient care and increasing costs for many patients.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.